REFERENCES
Register of Drugs in Russia, Infarm Chem, Moscow (2003).
General Pharmacopoeial Article FS 42–0003–00. Dissolution.
State Industrial Standard OST 91500.05.001.00. Drug Quality Standards. Main Stipulations.
A. l. Tentsova and I. S. Azhgikhin, Medicinal Forms and Therapeutic Efficacy of Drugs [in Russian], Meditsina, Moscow (1974).
Bio-International 2: Bioavailability, Bioequivalence and Pharmacokinetic Studies. International Conference of F. I. P., Munich, Germany, June 15–17 (1994), H. H. Blume and K. K. Midha (eds.), Medpharm Scientific Publ., Stuttgart (1995).
British Pharmacopoeia (2001).
Dissolution Discussion Group. Vol. 1: A User's Perspective on Dissolution,VanKel Technology Group (1999).
Dissolution Testing of Immediate Release Solid Oral Dosage Forms: Guidance for Industry, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (1997).
Eur. Pharmacopoeia, 4th ed. (2002).
L. J. Leeson and J. T. Carstensen, Dissolution Technology, Whitlock Press Inc. (1974).
The United States Pharmacopeia, 26th revision (2003).
L. E. Kholodov and V. P. Yakovlev, Clinical Pharmacokinetics [in Russian], Meditsina, Moscow (1985).
Drug Information for the Health Care Professional. USP DI, Vol. 1, 21st ed. MICROMEDEX Thomson Healthcare (2001).
R. Flindt, Biologie in Zahlen, Gustav Fischer, Stuttgart (1988)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dorofeev, V.L., Titov, I.V., Kochin, V.Y. et al. Using the Drug Dissolution Test for the Characterization of Generics: Ofloxacin Tablets. Pharmaceutical Chemistry Journal 38, 264–266 (2004). https://doi.org/10.1023/B:PHAC.0000042092.05652.bc
Issue Date:
DOI: https://doi.org/10.1023/B:PHAC.0000042092.05652.bc